[1]
|
张琪, 薛庆亮. 良恶性胸腔积液诊断的临床进展[J]. 临床肺科杂志, 2017, 22(11): 2101-2105.
|
[2]
|
Light, R.W. and Lee, Y.C.G. (2008) Textbook of Pleural Diseases. 2nd Edition, CRC Press, Boca Raton.
|
[3]
|
Ip, H., Sivakumar, P., McDermott, E.A., et al. (2019) Multidisciplinary Approach to Connective Tissue Disease (CTD) Related Pleural Effu-sions: A Four-Year Retrospective Evaluation. BMC Pulmonary Medicine, 19, Article No. 161.
https://doi.org/10.1186/s12890-019-0919-2
|
[4]
|
Choi, B.Y., Yoon, M.J., Shin, K., Lee, Y.J. and Song, Y.W. (2015) Characteristics of Pleural Effusions in Systemic Lupus Erythematosus: Differential Diagnosis of Lupus Pleuritis. Lupus, 24, 321-326.
https://doi.org/10.1177/0961203314555171
|
[5]
|
Pang, Y., An, J., Shu, W., et al. (2019) Epidemiology of Extrap-ulmonary Tuberculosis among Inpatients, China, 2008-2017. Emerging Infectious Diseases, 25, 457-464. https://doi.org/10.3201/eid2503.180572
|
[6]
|
Koegelenberg, C.F.N., Shaw, J.A., Irusen, E.M. and Lee, Y.C.G. (2018) Contemporary Best Practice in the Management of Malignant Pleural Effusion. Therapeutic Advances in Respira-tory Disease, 12, Article ID: 1753466618785098.
https://doi.org/10.1177/1753466618785098
|
[7]
|
Afful, B., Murphy, S., Antunes, G. and Dudzevicius, V. (2008) The Characteristics and Causes of Pleural Effusions in Kumasi Ghana—A Prospective Study. Tropical Doctor, 38, 219-220. https://doi.org/10.1258/td.2007.070275
|
[8]
|
张立杰, 刘宇红, 高静韬, 陈梓, 李亮. 世界卫生组织2020年《整合版结核病指南模块四:耐药结核病治疗》解读[J]. 中华结核和呼吸杂志, 2021, 44(4): 349-353.
|
[9]
|
Antonangelo, L., Faria, C.S. and Sales, R.K. (2019) Tuberculous Pleural Effusion: Diagnosis & Man-agement. Expert Review of Respiratory Medicine, 13, 747-759. https://doi.org/10.1080/17476348.2019.1637737
|
[10]
|
陈永. 多项生物指标联合检测对鉴别良恶性胸腔积液的诊断价值[D]: [硕士学位论文]. 南充: 川北医学院, 2020.
|
[11]
|
中国肺癌防治联盟, 中华医学会呼吸病学分会肺癌学组, 中国医师协会呼吸医师分会肺癌工作委员会. 肺癌筛查与管理中国专家共识[J]. 国际呼吸杂志, 2019, 39(21): 1604-1615.
|
[12]
|
张慧. 血清和胸水CEA, CA125及胸水ADA, LDH检测在胸腔积液中的诊断价值[D]: [硕士学位论文]. 杭州: 浙江大学, 2012.
|
[13]
|
何丽美. 联合检测生物标志物对鉴别良恶性胸腔积液的诊断价值[D]: [硕士学位论文]. 广州: 广州医科大学, 2015.
|
[14]
|
艾春芳. 乳酸脱氢酶同工酶检测初探[J]. 医学信息, 2011, 24(2): 494-495.
|
[15]
|
徐丹, 荣阳, 刘晓华. 胸腔积液乳酸脱氢酶和同工酶的分析与检验学研究[J]. 中国医药指南, 2018, 16(21): 154-155.
|
[16]
|
陈娟娟, 李亚云, 张晓东. 乳酸脱氢酶与白蛋白比值在小细胞肺癌患者预后评估中的价值[J]. 南通大学学报(医学版), 2022, 42(1): 74-77.
|
[17]
|
Petrelli, F., Cabiddu, M., Coinu, A., et al. (2015) Prognostic Role of Lactate Dehydrogenase in Solid Tumors: A Systematic Review and Meta-Analysis of 76 Studies. Acta Oncologica, 54, 961-970.
https://doi.org/10.3109/0284186X.2015.1043026
|
[18]
|
朱志真, 石建华, 侯森. 恩度联合顺铂局部治疗非小细胞肺癌合并恶性胸腔积液的疗效及对VEGF, HIF-1α的影响[J]. 实用癌症杂志, 2014(7): 855-857.
|
[19]
|
郑伟, 康静波, 温居一, 王静. 重组人血管内皮抑制素联合顺铂对恶性胸腔积液患者VEGF、EGFR及肿瘤标志物的影响[J]. 实用临床医药杂志, 2016, 20(23): 32-35.
|
[20]
|
胡建英, 王雅敏, 陈静, 等. 白细胞介素-18及血管内皮生长因子检测对结核性和恶性胸腔积液的鉴别诊断[J]. 临床误诊误治, 2009, 2(3): 1-3.
|
[21]
|
Zeng, N., Wan, C., Qin, J., Wu, Y., Yang, T., Shen, Y., Wen, F. and Chen, L. (2017) Diagnostic Value of Interleukins for Tuberculous Pleural Ef-fusion: A Systematic Review and Meta-Analysis. BMC Pulmonary Medicine, 17, Article No. 180. https://doi.org/10.1186/s12890-017-0530-3
|
[22]
|
Burgler, S., Ouaked, N., Bassin, C., Basinski, T.M., Mantel, P.Y., Siegmund, K., Meyer, N., Akdis, C.A. and Schmidt-Weber, C.B. (2009) Differentiation and Functional Analysis of Hu-man TH17 Cells. Journal of Allergy and Clinical Immunology, 123, 588-595. https://doi.org/10.1016/j.jaci.2008.12.017
|